The Drugs For Neglected Diseases Initiative (DNDi) is an independent, needs-driven, not-for-profit entity which develops drugs and other health tools for people suffering from neglected diseases - diseases that fall outside the scope of market-driven research and development (R&D), because they do not constitute a profitable market.

The Initiative came into being in 2003 when seven organisations from around the world joined forces to establish the DNDi: five public sector institutions - the Oswaldo Cruz Foundation from Brazil, the Indian Council for Medical Research, the Kenya Medical Research Institute, the Ministry of Health of Malaysia and France's Pasteur Institute; one humanitarian organisation - Médecins sans Frontières (MSF); and one international research organisation - the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).

DNDi has built regional networks of scientists actively involved in the research of new drugs for neglected diseases in Asia, Africa and Latin America. DNDi currently has regional liaison officers in Kenya and Brazil.

Website: www.dndi.org [new window]

Drugs for Neglected Diseases Initiative (DNDi)
1 place de Saint Gervais
1201 Geneva
Switzerland
Tel: + 41 (0) 22 906 9230
Fax. +41 (0) 22 906 9231
email: dndi@dndi.org

<< Return to list of NGO profiles